Therapeutic protein production Plants

The idea of using plant systems for the production of recombinant proteins has ceased to be a challenge to become a reality and alternative for the biopharmaceutical industry. There are several therapeutic products that are in various stages of preclinical and clinical development. However, within plant systems there is a wide variety, with the choice of plant expression system, crucial in the successful development of a biologic. Usually plant systems have a number of drawbacks at a molecular level, which decrease the level of expression of any exogenous protein therefore Agroaxis in collaboration with public is developing genetically modified plants to increase levels of expression. Currently, the development of these studies has led to tenfold increase production levels compared to other plant body, without affecting the product quality.


More on Agroaxis

The advances in molecular biology and more particularly recombinant DNA technology has allowed nutritionally valuable products, healthcare and industry , can be produced in large quantities at low cost and with increased biosafety.
The idea of using plant systems for the production of recombinant proteins has ceased to be a challenge to become a reality and alternative for the biopharmaceutical industry.

AGROAXIS decided to use and adapt the System NGS® to all their technology platforms to respond to the growing need of a new culture technologies and as a result of water scarcity and soil low yields increasingly overexploited.

Latest News

  • Agroaxis hires three more technologists with the grant Inncorpora TU of the Ministry of Economy and Competitiveness
  • Agroaxis creates the first GreenMab┬« technology platform with plants Snuff “Human “Insulin for obtaining
  •  

    Copyright 2013 Agroaxis. All Rights Reserved